Literature DB >> 9666019

Characterization of Neisseria meningitidis strains causing disease in complement-deficient and complement-sufficient patients.

C A Fijen1, E J Kuijper, J Dankert, M R Daha, D A Caugant.   

Abstract

Serotyping and serosubtyping of meningococci showed no difference between isolates from 44 complement-deficient persons and from 50 complement-sufficient persons with meningococcal disease. Multilocus enzyme electrophoretic typing of the meningococci revealed 54 electrophoretic types that were equally distributed among isolates from complement-deficient and complement-sufficient patients. Analysis of strains isolated from eight complement-deficient persons with 11 recurrences of meningococcal disease showed that one strain was identical to the strain previously isolated from the same individual. Our results indicate that there are no differences between the clonal distributions of strains infecting complement-deficient and complement-sufficient patients. Most recurrences were infections caused by different strains.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9666019      PMCID： PMC105045     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  18 in total

1.  The carrier state: Neisseria meningitidis.

Authors:  C V Broome
Journal:  J Antimicrob Chemother       Date:  1986-07       Impact factor: 5.790

2.  Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups.

Authors:  C A Fijen; E J Kuijper; A J Hannema; A G Sjöholm; J P van Putten
Journal:  Lancet       Date:  1989-09-09       Impact factor: 79.321

3.  Clones of serogroup B Neisseria meningitidis causing systemic disease in The Netherlands, 1958-1986.

Authors:  D A Caugant; P Bol; E A Høiby; H C Zanen; L O Frøholm
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

4.  Meningococcal carriage in a population of "normal" families.

Authors:  S Greenfield; P R Sheehe; H A Feldman
Journal:  J Infect Dis       Date:  1971-01       Impact factor: 5.226

5.  Natural serum bactericidal activity against Neisseria meningitidis isolates from disseminated infections in normal and complement-deficient hosts.

Authors:  S C Ross; H M Berberich; P Densen
Journal:  J Infect Dis       Date:  1985-12       Impact factor: 5.226

6.  Multilocus genotypes determined by enzyme electrophoresis of Neisseria meningitidis isolated from patients with systemic disease and from healthy carriers.

Authors:  D A Caugant; K Bøvre; P Gaustad; K Bryn; E Holten; E A Høiby; L O Frøholm
Journal:  J Gen Microbiol       Date:  1986-03

Review 7.  Inherited complement deficiency states: implications for immunity and immunological disease.

Authors:  A G Sjöholm
Journal:  APMIS       Date:  1990-10       Impact factor: 3.205

8.  Recurrent meningococcal septicaemia and properdin deficiency.

Authors:  N A Cunliffe; N Snowden; E M Dunbar; M R Haeney
Journal:  J Infect       Date:  1995-07       Impact factor: 6.072

9.  Complement and immunoglobulin studies in 15 cases of chronic meningococcemia: properdin deficiency and hypoimmunoglobulinemia.

Authors:  H E Nielsen; C Koch; B Mansa; P Magnussen; O J Bergmann
Journal:  Scand J Infect Dis       Date:  1990

10.  Immune response to tetravalent meningococcal vaccine: opsonic and bactericidal functions of normal and properdin deficient sera.

Authors:  C Söderström; J H Braconier; H Käyhty; A G Sjöholm; B Thuresson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-03       Impact factor: 3.267
View more
  4 in total

Review 1.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

2.  A non membrane-targeted human soluble CD59 attenuates choroidal neovascularization in a model of age related macular degeneration.

Authors:  Siobhan M Cashman; Kasmir Ramo; Rajendra Kumar-Singh
Journal:  PLoS One       Date:  2011-04-28       Impact factor: 3.240

3.  Soluble CD59 expressed from an adenovirus in vivo is a potent inhibitor of complement deposition on murine liver vascular endothelium.

Authors:  Jarel Gandhi; Siobhan M Cashman; Rajendra Kumar-Singh
Journal:  PLoS One       Date:  2011-06-24       Impact factor: 3.240

Review 4.  Meningococcal disease and the complement system.

Authors:  Lisa A Lewis; Sanjay Ram
Journal:  Virulence       Date:  2013-10-08       Impact factor: 5.882
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.